Wen-Tung Hsu , Keng-Yi Wu , Wu-Hsien Kuo , Wen-Hsiu Hsu , Yu-Lian Lai , Yi-Yu Tu , Kwang-Yang Tsai , Li-Mien Chen
{"title":"Serum adiponectin and glucose in patients with hepatitis B virus infection","authors":"Wen-Tung Hsu , Keng-Yi Wu , Wu-Hsien Kuo , Wen-Hsiu Hsu , Yu-Lian Lai , Yi-Yu Tu , Kwang-Yang Tsai , Li-Mien Chen","doi":"10.1016/j.bgm.2014.08.001","DOIUrl":null,"url":null,"abstract":"<div><p>Adiponectin is considered a modulator of glucose metabolism. Hypoadiponectinemia was reported to be associated with glucose metabolism and metabolic syndrome, and had been found in patients with hepatitis B virus (HBV) and hepatitis C virus infections. However, little is known about the role of adiponectin in patients with HBV infection. Fifty-five patients with HBV infection and 52 healthy individuals were included in this study. We found that serum adiponectin was significantly lower in patients with HBV infection. We also found that HBV-infected patients with hemoglobin A1C ≥6.5% had a lower adiponectin level than those with hemoglobin A1C <6.5%. In conclusion, hypoadiponectinemia occurs in patients with HBV infection, and adiponectin may play a role in the pathogenesis of glucose metabolism in these patients.</p></div>","PeriodicalId":100178,"journal":{"name":"Biomarkers and Genomic Medicine","volume":"6 4","pages":"Pages 180-182"},"PeriodicalIF":0.0000,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bgm.2014.08.001","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomarkers and Genomic Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221402471400063X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Adiponectin is considered a modulator of glucose metabolism. Hypoadiponectinemia was reported to be associated with glucose metabolism and metabolic syndrome, and had been found in patients with hepatitis B virus (HBV) and hepatitis C virus infections. However, little is known about the role of adiponectin in patients with HBV infection. Fifty-five patients with HBV infection and 52 healthy individuals were included in this study. We found that serum adiponectin was significantly lower in patients with HBV infection. We also found that HBV-infected patients with hemoglobin A1C ≥6.5% had a lower adiponectin level than those with hemoglobin A1C <6.5%. In conclusion, hypoadiponectinemia occurs in patients with HBV infection, and adiponectin may play a role in the pathogenesis of glucose metabolism in these patients.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
